A mathematical model for cancer treatment based on combination of anti-angiogenic and immune cell therapies

DOI10.1016/J.RINAM.2022.100330zbMATH Open1505.92105OpenAlexW4295815896MaRDI QIDQ2104157FDOQ2104157

Authors: Moria Sigron, Ophir Nave 

Publication date: 9 December 2022

Published in: Results in Applied Mathematics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.rinam.2022.100330

Recommendations

• Use of quasi-normal form to examine stability of tumor-free equilibrium in a mathematical model of BCG treatment of bladder cancer
• Mathematical modeling of an immune checkpoint inhibitor and its synergy with an immunostimulant
• Some promising approaches to tumor-immune modelling
• Stability analysis of a mathematical model for glioma-immune interaction under optimal therapy
• Mathematical modeling, analysis, and simulation of tumor dynamics with drug interventions

zbMATH Keywords

mathematical modelstability analysisVEGFcancer treatmentanti-VEGFangiogenictumor vasculature

Mathematics Subject Classification ID

Medical applications (general) (92C50) Stability of solutions to ordinary differential equations (34D20)

Cites Work

• Modeling immunotherapy of the tumor -- immune interaction
• A mathematical model of tumor-immune interactions
• A cancer treatment based on synergy between anti-angiogenic and immune cell therapies
• Analysis of the computational singular perturbation reduction method for chemical kinetics
• Invariant manifold methods for metabolic model reduction
• Use of quasi-normal form to examine stability of tumor-free equilibrium in a mathematical model of BCG treatment of bladder cancer
• A mathematical model of angiogenesis and tumor growth: analysis and application in anti-angiogenesis therapy
• On a modified version of ILDM approach: asymptotic analysis based on integral manifolds
• A mathematical model of Imatinib and interferon-Alpha combined treatment of chronic myeloid leukemia
• Predictive modeling of neuroblastoma growth dynamics in xenograft model after bevacizumab anti-VEGF therapy

Cited In (4)

• A feedback control model of comprehensive therapy for treating immunogenic tumours
• A cancer treatment based on synergy between anti-angiogenic and immune cell therapies
• A mathematical model for the effect of anti-angiogenic therapy in the treatment of cancer tumours by chemotherapy
• Use of quasi-normal form to examine stability of tumor-free equilibrium in a mathematical model of BCG treatment of bladder cancer

This page was built for publication: A mathematical model for cancer treatment based on combination of anti-angiogenic and immune cell therapies

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2104157)